Skip to main content
DA / EN
Menu
Research

Comprehensive health checks lower mortality in older men

A major Danish study conducted by the University of Southern Denmark (SDU) and Odense University Hospital has found that thorough health checks in men aged 60–64 help initiate cardiovascular disease prevention – and result in a marked drop in mortality rates.

By Nana Olejank Hansen, , 9/1/2025

Cardiovascular disease and blood clots are among the leading causes of death in men. However, experts estimate that up to 80 percent of cases can be prevented – for instance, through early detection and timely treatment.

As part of a Danish trial, large groups of men were offered a comprehensive health check, including scans, blood tests and blood pressure measurements. Researchers from the University of Southern Denmark (SDU) and Odense University Hospital (OUH) have now assessed the impact of these checks in men aged 60 to 64, as part of the DANCAVAS II study.

– Among those who accepted the health check, we observed a 17 percent reduction in mortality compared to the control group – the men who were not offered a check, explains Jes Lindholt, professor of vascular surgery at the Department of Clinical Research, SDU and OUH, and one of the study’s lead researchers.

– That’s a greater benefit than any previous screening programme has ever demonstrated.

Doctor analyzing heart CT scan on dual computer monitors in a medical diagnostic setting.

The study involved more than 31,000 men in Denmark, 6,000 of whom were invited to take part in the health check. Among those who accepted the offer, mortality rates were 17 percent lower seven years after screening.

Screened men are more likely to begin preventive treatment

The study also found that men who were screened were more likely to start preventive medication.

– We know that up to 80 percent of cases of cardiovascular disease and blood clots can be prevented, so we’re pleased to see that the health checks have helped set that process in motion, says Axel Diederichsen, professor of cardiology at the Department of Clinical Research, SDU and OUH.

Preventive treatment typically involves cholesterol-lowering drugs such as statins and blood-thinning medication like aspirin. While statins are generally considered safe and effective, the researchers observed a higher incidence of serious bleeding among men taking aspirin.

– This suggests that aspirin should be prescribed with great caution in this age group – even when there is evidence of coronary artery calcification, explains Axel Diederichsen.

– It’s something doctors should be mindful of when prescribing preventive treatment.

Older men may benefit even more from screening

The researchers point out that an earlier study (DANCAVAS 1) showed even greater benefits in men aged 65 to 69, suggesting that screening may be even more effective in slightly older age groups.

They also emphasise the need for future studies to investigate whether women could benefit from a similar offer.

The findings were recently presented at ESC 2025 – the world’s largest cardiology conference.

About the study

The study included 31,000 men in Denmark aged 60 to 64. Of these, 6,000 were invited to take part in a comprehensive health check involving scans, blood tests and blood pressure measurements.

Of those invited, 62 percent accepted. In this group, researchers observed a 17% reduction in mortality – a statistically significant result, given the size of the sample.

Mortality rates were assessed seven years after the health checks were carried out.

The study is published in European Health Journal. The findings were recently presented at ESC 2025 – the world’s largest cardiology conference.

 

Meet the researcher

Jes S. Lindholt is Professor and Consultant in Vascular Surgery at the Research Unit for Heart, Lung and Vascular Surgery at the Department of Clinical Research, SDU, and the Department of Cardiothoracic and Vascular Surgery T, Odense University Hospital.

Contact

Meet the researcher

Axel Diederichsen is Professor of Cardiology at the Research Unit for Cardiology at the Department of Clinical Research, SDU, and the Department of Cardiology B, Odense University Hospital.

Contact

Read the study

The study: "Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial" is published in European Health Journal

https://doi.org/10.1093/ eurheartj/ehaf704

Editing was completed: 01.09.2025